Molecure achieved key milestones in the development of its innovative therapies in 2024 and plans to accelerate research and development in its most advanced clinical programs: OATD-01 and OATD-02. A ...
Europe's leading e-commerce logistics enabler, announced strong results for the fourth quarter and full year of 2024. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results